BRCA1 and breast cancer: Additional indications classified as “Other” (9.6%) in Table 1 included chronic pelvic pain, ovarian cyst with a history of breast cancer, a BRCA1 mutation, uterine cavity polyp, and lower urinary tract symptoms.